Download PDF
Geburtshilfe Frauenheilkd 2000; 60(6): 297-301
DOI: 10.1055/s-2000-9535
ÜBERSICHT

Georg Thieme Verlag Stuttgart · New York

Screening asymptomatischer Frauen auf Endometriumkarzinom mit besonderer Berücksichtigung des Screenings unter Tamoxifen-Behandlung

Screening for Endometrial Carcinoma in Asymptomatic Women, Including Those Receiving TamoxifenE. Petru1 , S.  Kurschel2 , K. Walsberger1
  • 1 Geburtshilflich-gynäkologische Universitätsklinik Graz
  • 2 Neurochirurgische Universitätsklinik Graz
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Beim Endometriumkarzinom tritt als Frühsymptom in den meisten Fällen eine Postmenopausenblutung auf. 75 % der Patientinnen weist zu diesem Zeitpunkt ein Stadium I auf. Die 5-Jahres-Überlebensrate liegt beim Endometriumkarzinom um 75 %. Ein generelles Screening von Frauen ohne Blutungsanomalien, abnormen Fluor und ohne andere Symptomatik erscheint nicht indiziert. Dies gilt in gleicher Weise auch für Patientinnen unter Tamoxifentherapie wegen eines Mammakarzinoms.

Abstract

Most patients with endometrial carcinoma present with postmenopausal vaginal bleeding and 75 % will have stage I disease. The overall 5-year survival rate of patients with endometrial carcinoma is about 75 %. Routine screening of women without postmenopausal bleeding, abnormal vaginal discharge or other symptoms does not seem justified. The same applies to patients receiving tamoxifen.

Literatur

  • 1 Archer D, McIntre-Seltman K, Wilborn W, Dowling E, Cone F, Creasy G, Kafrissen M. Endometrial morphology in asymptomatic postmenopausal women.  Amer J Obstet Gynecol. 1991;  165 317-322
    PubMedSearch in Google Scholar
  • 2 Barakat R. Screening for endometrial cancer in a patient receiving tamoxifen for breast cancer.  J Clin Oncol. 1999;  17 1967-1968
    PubMedSearch in Google Scholar
  • 3 Barakat R, Gilewski T, Almadrones L, Saigo P, Venkatraman E, Hoskins W. The effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study.  Proc ASCO. 1999;  18
    PubMedSearch in Google Scholar
  • 4 Berliere M, Charles A, Galant C, Donnez J. Uterine side effects of tamoxifen: A need for systematic pretreatment screening.  Obstet Gynecol. 1998;  91 40-44
    CrossrefPubMedSearch in Google Scholar
  • 5 Bertelli G, Venturini M, Del Mastro L, Garrone O, Cosso M, Gustavino C, Cusimano E, Guido T, Nicolo G, Rosso R. Tamoxifen and the endometrium: findings of pelvic ultrasound examination and endometrial biopsy in asymptomatic breast cancer patients.  Breast Cancer Res Treat. 1998;  47 41-46
    CrossrefPubMedSearch in Google Scholar
  • 6 Brooks S, Yeatts-Peterson M, Baker S, Reuter K. Thickened endometrial stripe and/or endometrial fluid as a marker of pathology: Fact or fancy?.  Gynecol Oncol. 1996;  63 19-24
    CrossrefPubMedSearch in Google Scholar
  • 7 Burk J, Lehman H, Wolf F. Inadequacy of Papanicolao smears in the detection of endometrial cancer.  New Engl J Med. 1974;  270 191-192
    PubMedSearch in Google Scholar
  • 8 Cecchini S, Ciatto S, Bonardi R, Mazzotta A, Grazzini G, Pacini P, Muraca M. Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen.  Gynecol Oncol. 1996;  60 409-411
    CrossrefPubMedSearch in Google Scholar
  • 9 Cohen I, Rosen D, Shapira J, Cordoba M, Gilboa S, Altaras M, Yigael D, Beyth Y. Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and nontreated asymptomatic postmenopausal breast cancer patients.  Gynecol Oncol. 1994;  52 185-190
    CrossrefPubMedSearch in Google Scholar
  • 10 Cohen I, Tepper R, Rosen D, Shapira J, Cordoba M, Dror Y, Altaras M, Beyth Y. Continous tamoxifen treatment in asymptomatic postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies.  Gynecol Oncol. 1994;  55 138-143
    CrossrefPubMedSearch in Google Scholar
  • 11 Early Breast Cancer Trialist's Collaborative Group . Tamoxifen for early breast cancer: an overview of the randomised trials.  Lancet. 1998;  351 1451-1467
    CrossrefPubMedSearch in Google Scholar
  • 12 Eddy G, Wojtowycz M, Piraino P, Mazur M. Papanicolao smears by the Bethesda system in endometrial malignancy: Utility and prognostic importance.  Obstet Gynecol. 1997;  90 999-1003
    CrossrefPubMedSearch in Google Scholar
  • 13 Franchi M, Ghezzi F, Donadello N, Zanaboni F, Beretta P, Bolis P. Endometrial thickness in tamoxifen-treated patients: An independent predictor of endometrial disease.  Obstet Gynecol. 1999;  93 1004-1008
    CrossrefPubMedSearch in Google Scholar
  • 14 Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H, Yamasaki F. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.  Gynecol Oncol. 1999;  72 273-277
    CrossrefPubMedSearch in Google Scholar
  • 15 Grönross M, Salmi T, Vuento M, Jalava A, Tyrkkö J, Maatela J, Aromaa A, Siegberg R, Savolainen E. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension.  Cancer. 1993;  71 1279-1282
    PubMedSearch in Google Scholar
  • 16 Gull B, Karlsson B, Milsom I, Wikland M, Granberg S. Transvaginal sonography of the endometrium in a representative sample of postmenopausal women.  Ultras Obstet Gynecol. 1996;  7 322-327
    PubMedSearch in Google Scholar
  • 17 Kedar R, Bourne T, Collins W, Ashley S, Cosgrove D, Campbell S. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial.  Lancet. 1994;  343 1318-1321
    CrossrefPubMedSearch in Google Scholar
  • 18 Koss L, Schreiber K, Oberlander S, Moukhtar M, Leveine H, Moussouris H. Screening of asymptomatic women for endometrial cancer.  Obstet Gynecol. 1981;  57 681-691
    PubMedSearch in Google Scholar
  • 19 Langer R, Pierce J, O'Hanlan K, Johnson S, Espeland M, Trabal J, Barnabei V, Merino M, Scully R. Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease.  New Engl J Med. 1997;  337 1792-1798
    CrossrefPubMedSearch in Google Scholar
  • 20 Lindgren R, Mattson L, Andersson K, Lagrelius A, Sandin K, Karlsson K, Risberg B. Transvaginal ultrasonography and endometrial histology in peri- and postmenopausal women on hormone replacement therapy.  Brit J Obstet Gynaecol. 1999;  106 421-426
    PubMedSearch in Google Scholar
  • 21 Love C, Muir B, Scrimgeour J, Leonard R, Dillon P, Dixon J. Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening.  J Clin Oncol. 1999;  17 2050-2054
    PubMedSearch in Google Scholar
  • 22 McGonigle K, Marx H, Morgan R, Maryon T, Chen E, Roy S, Vasilev S, Wong P, Roach L, Wilczynski P, Simpson J. Uterine effects of tamoxifen: A prospective study.  Gynecol Oncol. 1994;  74 324-325
    PubMedSearch in Google Scholar
  • 23 Mourits M, Van der Zee A, Willemse H, Hoor T, Hollema H, De Vries E. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.  Gynecol Oncol. 1999;  73 21-26
    CrossrefPubMedSearch in Google Scholar
  • 24 Obwegeser R, Chalubinsky K, Turnheim K, Auerbach L. Klinische Relevanz sonomorphologischer Veränderungen des Endometriums unter Tamoxifentherapie.  Geburtsh Frauenheilk. 1997;  57 371-375
    PubMedSearch in Google Scholar
  • 25 Osmers R, Völksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma?.  Lancet. 1990;  335 1569-1571
    CrossrefPubMedSearch in Google Scholar
  • 26 Runowicz C, Costantino J, Kavanagh M, Geyer C, Daly M, Lewis G, Levy L, Wickerham D, Wieand H. National surgical adjuvant breast and bowel project (NSABP) breast cancer prevention trial summary analysis of transvaginal sonography and endometrial biopsy in detecting endometrial pathology.  Proc ASCO. 1999;  18
    PubMedSearch in Google Scholar
  • 27 Schmidt T, Rein D, Römer T, Straube W, Mallmann P. Hysteroskopische Befunde bei asymptomatischen postmenopausalen Patientinnen mit sonographisch suspektem Endometrium - Ein Vergleich mit sonographischen und histologischen Befunden.  Geburtsh Frauenheilk. 1999;  59 163-166
    Thieme ConnectPubMedSearch in Google Scholar
  • 28 Seoud M, Shamseddine A, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N, Azar G, Kaspar H. Tamoxifen and endometrial pathologies: A prospective study.  Gynecol Oncol. 1999;  75 15-19
    CrossrefPubMedSearch in Google Scholar
  • 29 Tepper R, Beyth Y, Altaras M, Zalel Y, Shapira J, Cordoba M, Cohen I. Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients.  Gynecol Oncol. 1997;  64 386-391
    CrossrefPubMedSearch in Google Scholar
  • 30 Timmermann D, Deprest J, Bourne T, Van der Berghe I, Collins W, Vergote I. A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen.  Amer J Obstet Gynecol. 1998;  179 62-70
    PubMedSearch in Google Scholar
  • 31 Tsuda H, Kawabata M, Yamamoto K, Inoue T, Umesaki N. Prospective study to cmpare endometrial cytology and transvaginal ultrasonography for identification of endometrial malignancies.  Gynecol Oncol. 1997;  65 383-386
    CrossrefPubMedSearch in Google Scholar
  • 32 Turaine P, Driguez P, Cartier I, Yaneva H, Kuttenn F, Mauvais-Jarvis P. Lack of induction of endometrial hyperplasia with tamoxifen.  Lancet. 1995;  345 254-255
    CrossrefPubMedSearch in Google Scholar
  • 33 Vuento M, Maatela J, Tyrkkö J, Laippala P, Grönroos M, Salmi T. A longitudinal study of screening for endometrial cancer by endometrial biopsy in diabetic females.  Int J Gynecol Cancer. 1995;  5 390-395
    CrossrefPubMedSearch in Google Scholar
  • 34 Vuento M, Stenman U, Pirhonen J, Mäkinen J, Laippala P, Salmi T. Significance of a single CA 125 assay combined with ultrasound in the early detection of ovarian and endometrial cancer.  Gynecol Oncol. 1997;  64 141-146
    CrossrefPubMedSearch in Google Scholar
  • 35 Vuento M, Pirhonen J, Mäkinen J, Tyrkkö J, Laippala P, Grönroos M, Salmi T. Screening for endometrial cancer in asymptomatic postmenopausal women with conventional and colour Doppler sonography.  Brit J Obstet Gynaecol. 1999;  106 14-20
    PubMedSearch in Google Scholar

Prof. Dr. Edgar Petru

Geburtshilflich-gynäkologische Universitätsklinik

Auenbruggerplatz 14

8036 Graz

Österreich